What is the recommended monitoring interval for a patient with high disease activity RA whose treatment changes?

• A. Every 1-2 months
• B. Every 3-4 months
• C. Every 6 months
• D. Weekly

Answer: (A)

When disease activity is high and you’ve changed treatment, you need to closely verify that the new regimen is producing a meaningful response and adjust promptly if it isn’t. In practice, reassessment is typically planned every 4–8 weeks after a therapy change, with a common target of a 1–2 month interval. This timing reflects how long RA medications usually take to show measurable effects (often 4–12 weeks) and allows timely optimization to control inflammation, prevent joint damage, and move toward low disease activity or remission. At each visit, you’d evaluate the updated disease activity (joint counts, patient/global assessments, inflammatory markers), and also monitor safety as needed. Less frequent monitoring (every 3–4 months or longer) risks missing nonresponse or flares, while weekly visits aren’t necessary unless the patient is unstable.